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Abstract Apoptosis signal-regulating kinase 1–interacting
(ASK1-interacting) protein-1 (AIP1) is a newly identified novel
member of the Ras GTPase-activating protein family, which
has been implicated in cell growth inhibition and cell apoptosis.
However, the effects of AIP1 in Alzheimer’s disease (AD) are
unknown. In the present study, we found that AIP1 was elevat-
ed in the brain of AD Tg2576 mice and Aβ1-42 treated brain
cerebral microvascular endothelial cells (CECs). Aβ1-42 treat-
ment induced the interaction of AIP1 and apoptosis signal-
regulating kinase 1 (ASK1), which led to dissociation of
ASK1 and its inhibitor 14-3-3. Dissociation of ASK1 from
14-3-3 leads to ASK1 activation. Indeed, Aβ1-42 dephosphor-
ylated ASK1 at Ser-967, suggesting that Aβ1-42 increased
ASK1 activity. Importantly, disassociation of ASK1 and 14-3-
3 induced by Aβ1–42 could be rescued by silence of AIP1. In
addition, down-regulation of AIP1 also led to attenuation of the
activation of JNK, as well as p53, downstream signaling targets
of ASK1. AIP1 silencing attenuated the pro-apoptotic effects of
Aβ1-42 on CECs. We propose that AIP1 mediates Aβ induced
ASK1 activation by facilitating dissociation of 14-3-3, suggest-
ing a novel mechanism for Aβ-induced apoptosis in CECs.
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Introduction
Alzheimer's disease (AD) is neuropathologically character-
ized by intracellular neurofibrillary tangles (NFTs) and
extracellular senile plaques (Roberson and Mucke 2006).
The main component of extracellular senile plaques is β-
amyloid (Aβ) (Buoso et al. 2010). Aβ has been reported as
a primary mediator of neuronal degeneration in AD
(Yankner et al. 1989; Sheng et al. 2009a). Multiple lines
of evidence suggest that Aβ induces apoptosis not only in
neurons, but also in cerebral endothelial cells (CECs) (Yin
et al. 2002). CECs play a critical role in blood–brain barrier
(BBB) to shield the brain from damage by harmful circu-
lating toxins or deleterious cellular elements. Currently,
cerebrovascular pathology and AD are strongly linked.
Aβ deposition in cerebrovascular surface forms cerebral
amyloid angiopathy (CAA), which has been proved to play
a critical role in the progress of AD (Yamada and Naiki
2012). As a result, CEC apoptosis appears to be a contrib-
uting factor in Aβ-induced cerebrovascular degeneration.
However, the mechanisms underlying the CEC apoptosis
are still needed to be elucidated.
Apoptosis signal-regulating kinase 1–interacting
(ASK1-interacting) protein-1 (AIP1) is a recently identified
novel member of the Ras GTPase-activating protein family.
It is also known as DAB2-interacting protein (DAB2IP)
and has been implicated in cell growth inhibition and cell
apoptosis (Chen et al. 2005). AIP1 has been reported to
function as a positive regulator in cell apoptosis by medi-
ating activation of the apoptotic kinase apoptosis signal-
regulating kinase 1 (ASK1). AIP1 binds preferentially to
dephosphorylate ASK1 and recruited AIP1 that enhances
ASK1-induced JNK activation (Zhang et al. 2003a).
Previous studies have demonstrated that AIP1 expression
is often down-regulated in various human cancers, suggest-
ing that AIP1 serves as an inhibitor of cell survival and
Huaiming Wang and Lijing Fan have an equal contribution.
H. Wang : L. Fan :H. Wang : Z. Du (*)
Department of Neurology, The 89th Hospital of People’s Liberation




Department of medicine, Shandong Province Weifang Brain
hospital, Weifang, China
J Mol Neurosci (2015) 55:227–232
DOI 10.1007/s12031-014-0310-y
growth (Yano et al. 2004). However, whether AIP1 is
involved in the neurodegenerative process of AD is still
unknown. In this study, we aimed to determine whether




Tg2576 mice (18–24 months) overexpressing human
APP695 with the “Swedish” mutation develop memory
deficits and plaques with age were used in this study. The
transgenic mice were purchased from Taconic Farms
(Germantown, USA). Mice were maintained on mixed
C57Bl6/SJL background by mating heterozygous Tg2576
males to C57Bl6/SJL F1 females. Age-matched non-
transgenic littermates of the Tg2576 mice (Control) were
used as control animals. All experimental procedures were
carried out under protocol approved by the Institutional
Animal Care and Use Committee in the 89th Hospital of
People's Liberation Army and were in accordance with the
89th Hospital of People's Liberation Army guidelines for
the care and use of laboratory animals.
Cell Culture, Treatment, and Transfection
The human brain cerebral microvascular endothelial cells
(CECs) were purchased from Cell Systems and cultured
in EBM-2 media with supplemental growth factors ac-
cording to manufacturer’s instructions (Shi et al. 2013).
Aβ1-42 (American Peptide, USA) was dissolved in
Hexafluoroisopropanol (Sigma, USA) for 2 days at room
temperature (RT), and the lyophilized peptide was dis-
solved in dimethylsulfoxide (DMSO). Ten to twenty
micromolar of Aβ1-42 was used to treat cells for 48 h.
AIP1 knockdown experiments were conducted by
transfecting with nonspecific or AIP1-specific small in-
terfering RNA (siRNA) (50 nM, Santa Cruz) using
Lipofectamine RNAiMAX (Invitrogen).
Real Time Quantitative Polymerase Chain Reaction (PCR)
Total RNA was extracted from mouse whole brain tissue
and CECs with TRIzol Reagent (Invitrogen). Two micro-
gram target RNA in each group was converted into
complementary DNA (cDNA) by using iScript™ RT-
PCR Kit (Bio-rad, USA). The synthesized cDNA prod-
ucts were used for real time PCR with SYBR Green
Supermix (Bio-Rad Laboratories) as the fluorescent
DNA intercalating agent. The following primers were
used in this study: AIP1, 5′-CCTGCGCGTATCAGTC
CTTACCA-3′ (forward); 5′-GGGTTCAGAGCCCTCC




For immunoprecipitation assays, cells were lysed by cell
lysis buffer containing 50 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 0.1 % Nonidet P-40, 1 mM dithiothreitol, protease
inhibitor mixture, sodium orthovanadate, and sodium fluo-
ride. Twenty millimolar sodium molybdate was used to
stabilize Hsp90 protein interactions. A total of 5 μg of
anti-HIF-1α antibody (Novus Biological, USA) was incu-
bated with 1 mg whole cell lysates to form the antigen-
antibody complex overnight at 4 °C. The formed antigen-
antibody complex was incubated with protein A/G-agarose
beads (Santa Cruz) for 2 h at 4 °C. After washed with
phosphate-buffered saline four times, the beads were eluted
in SDS sample buffer. Eluted protein samples were subject-
ed to 10 % sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and electrotransferred onto
polyvinylidene fluoride (PVDF) membranes (Millipore,
USA). PVDF membranes were blocked in blocking solu-
tion (5 % nonfat dry milk in tris-buffered saline containing
0.1 % Tween 20) for 2 h at room temperature. Then mem-
branes were sequentially incubated overnight with primary
antibody and horse radish peroxidase (HRP)-conjugated
secondary antibody for another 2 h. Blots were developed
with chemiluminescence technique (Santa Cruz
Biotechnology, USA) according to the manufacturer’s
instructions.
TUNEL Assay and DAPI Staining
DNA fragmentation is a characteristic hallmark of apo-
ptosis. The patterns of apoptosis were indexed by the
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL). Briefly, CECs were plated in Lab-
Tek® Chamber Slides (Nalgene Nunc, USA) and incu-
bated in the indicated medium. Upon completion of the
indicated treatment, apoptosis was determined by a com-
mercially available kit (Promega, Madison, WI, USA)
according to the manufacturer’s instructions. Nuclei were
counterstained with nuclear-specific dye 4, 6-diamidino-
2-phenylindole (DAPI). Fluorescence signals were re-
corded by using a fluorescence microscope and a digital
camera.
Statistical Analysis
All quantitative data are presented as mean ± SEM from at
least three separate experiments. One-way analysis of variance
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(ANOVA) was used to assess statistical significance of differ-
ences among treatment groups. P<0.05 was considered sta-
tistically significant.
Results
In order to examine whether the expression of AIP1 was
changed in AD, we investigated the expression levels of
AIP1 in the brains of Tg2576 mice at messenger RNA
(mRNA) levels and protein levels. As shown in Fig. 1a, real
time PCR studies showed a significant up-regulation in AIP1
mRNA level in Tg2576 mice compared to age-matched con-
trols. Western blot analysis also demonstrated that the protein
level of AIP1 was significantly elevated in the brains of
Tg2576 mice (Fig. 1b).
It was reported that AIP1 is highly expressed in the vascu-
lar endothelium (Zhang et al. 2008a). As Aβ was extensively
associated with vascular endothelium dysfunction in AD, we
investigated the effect of Aβ1-42 in the expression of AIP1 in
human primary cerebral endothelial cells (CECs). Isolated
CECS was treated with Aβ1-42 for 48 h, and the Western
blot result indicated that Aβ1-42 treatment led to a significant
elevation in AIP1 expression at both mRNA levels (Fig. 1c)
and protein levels (Fig. 1d).
Aβ1-42 dephosphorylated ASK1 at Ser-967, suggesting
that Aβ1-42 increased ASK1 activity (Fig. 2). Interaction of
AIP1 with endogenous ASK1 was determined by co-
immunoprecipitation with primary anti-AIP1 antibody
followed byWestern blot with ASK1 antibody. And the result
indicated that Aβ1-42 treatment induced the interaction of
AIP1 and ASK1 (Fig. 3a). 14-3-3 is an inhibitor of ASK1.
When binds to 14-3-3, ASK1 stays inactive. It was previously
shown that 14-3-3 associated with ASK1 via pSer-967
(Subramanian et al. 2004). Dissociation of ASK1 from 14-3-
3 leads to ASK1 activation, initialing intracellular apoptosis
pathways. Interestingly, co-immunoprecipitation results re-
vealed that Aβ1-42 abolished the association of 14-3-3 and
ASK1 (Fig. 3b). In order to examine whether AIP1 mediated
Aβ1-42-induced disassociation of ASK1 and 14-3-3, the as-
sociation of 14-3-3 and ASK1 was investigated following
siRNA mediated down-regulation of AIP1. The successful
silence of AIP1 was shown in Fig. 3c. Importantly, disassoci-
ation of ASK1 and 14-3-3 induced by Aβ1-42 could be
rescued by silence of AIP1 (Fig. 3d).
Activated ASK1 plays a critical role in apoptosis by stim-
ulating the downstream signaling events, especially JNK ac-
tivation. Indeed, down-regulation of AIP1 also led to attenu-
ation of the activation of JNK, as well as the expression of p53
(Fig. 4a), downstream signaling targets of ASK1, suggesting
that inhibition of AIP1 could prevent the activated apoptotic
Fig. 1 The expression level of A1P1 was increased in the brain of
Tg2576 mice and Aβ1-42 treated primary cerebral endothelial cells
(CECs). a Real time PCR analysis revealed that the mRNA level of
A1P1 was significantly increased in Tg2576 brains compared with con-
trols (*p<0.01 vs. controls, Student’s t test, n=6); b representative
immunoblot and quantification analysis revealed that the protein level
of A1P1 was significantly increased in Tg2576 brains compared with
age-matched controls (*p<0.01 vs. control, Student’s t test, n=6); actin
was used as an internal loading control. cCECswere treated with Aβ1-42
(10 or 20 μM) for 48 h, real time PCR analysis revealed that the mRNA
level of AIP1 was significantly increased after Aβ1-42 treatment
(*p<0.01 vs. untreated control, ANOVA, n=4); d CECs were treated
with Aβ1-42 (10 or 20 μM) for 48 h, representative immunoblot and
quantification analysis revealed that the protein level of AIP1 was signif-
icantly increased after Aβ1-42 treatment (*p<0.01 vs. untreated control,
ANOVA, n=4)
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signaling cascade induced by Aβ1-42. In order to determine
whether elevated AIP1 contributed to pro-apoptotic effects of
Aβ in CECs cells, TUNEL staining was used to detect the
apoptosis patterns after Aβ treatment. Five micromolar of
Aβ1-42 significantly promoted apoptosis in mouse primary
Fig. 3 Aβ1-42 promotes the interaction between AIP1 and ASK1, but
inhibits the interaction between 14-3-3 and ASK1. a After treated with
Aβ1-42 for 48 h, the cell lysates were immunoprecipitated (IP) by anti-
AIP1 antibody. The precipitate was immunoblotted (IB) with anti-ASK1;
representative blots of four independent experiments are shown. b After
treated with Aβ1-42 for 48 h, the cell lysates were immunoprecipitated
(IP) by anti-14-3-3 antibody. The precipitate was immunoblotted (IB)
with anti-ASK1. Representative blots of four independent experiments
are shown. c The expression of AIP1 was knocked down using small
RNA interferences, and Western blot analysis confirmed the successful
knockdown of AIP1; d Immunoprecipitated (IP) experiment demon-
strates that knockdown of AIP1 attenuated the disassociation between
14-3-3 and ASK1. Representative blots of four independent experiments
are shown
Fig. 4 Knockdown of AIP1 by small RNA interference mitigated Aβ1-
42 induced activation of JNK, induction of P53, and apoptosis. a After
transfected with AIP1 siRNA, cells were incubated with Aβ1-42 (20μM)
for 48 h, immunoblot and quantification analysis revealed that Aβ1-42-
induced up-regulation of phosphorylated JNK and P53 could be attenu-
ated by knockdown of AIP1 (*p<0.01 vs. Non-treatment; #p<0.01 vs.
Aβ1–42 treatment, n=4–5). b Silence of AIP1 prevents Aβ1-42
(20 μM)-induced apoptosis in CECs. Cells were stained using a TUNEL
Assay Kit. Nuclear DNAwas stained with DAPI (ANOVA; *p<0.001 vs.
non-treated control; #p<0.001 vs. Aβ1-42 treated group, n=4–5)Fig. 2 Aβ1-42-induced phosphorylation ofASK at Ser967. Phosphorylated
levels of ASK at Ser967 were examined byWestern blot analysis in CECs in
presence of Aβ1-42 (*p<0.01 vs. untreated control, ANOVA, n=3–4)
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CECs. However, AIP1 silencing attenuated the pro-apoptotic
effects of Aβ1-42 (Fig. 4b).
Discussion
AIP1 was initially identified as a binding partner for apoptosis
signaling kinase-1 (ASK1). It was reported AIP1 functions as
an adaptor molecule in TNF signaling (Zhang et al. 2003b). A
recent study demonstrated that AIP1 activated ASK1 by
recruiting phosphatase PP2A to dephosphorylate the 14-3-3
binding site on ASK1, leading to dissociation of this inhibi-
tory protein from the enzyme, thereby allowing activation by
the TNFR1 signaling complex (Min et al. 2008). As highly
expressed in endothelial cells, the biological function of AIP1
in vascular EC has been widely studied. AIP1 was reported to
function as an inhibitor of VEGFR2 signaling in vascular EC
surface, regulating angiogenesis and lymphangiogenesis
(Zhang et al. 2008b). However, to the best of our knowledge,
there is no report on the function of AIP1 in AD. So far, Aβ
has been implicated as the primary neurotoxic mediator in the
pathogenesis of AD (Sheng et al. 2009b). The mechanisms
underlying Aβ-induced apoptosis are complex. It was consid-
ered as a multifactorial process, including excessive formation
of reactive oxygen species, alteration of intracellular calcium
homeostasis (Demuro et al. 2010), and mitochondrial dys-
function (Leuner et al. 2012) and caspases activation
(Mattson 2006). However, the precise molecular mechanism
responsible for the apoptotic action of Aβ remains to be fully
characterized. Here, we reported the new mechanisms under-
lying Aβ-induced CECs apoptosis by investigating the roles
of AIP1. The level of AIP1 was increased in the brains of AD
Tg2576 mice, suggesting a potential role of AIP1 in the
pathogenesis of AD. Indeed, Aβ1-42 treatment promoted
the expression of AIP1. The elevated AIP1 binds to the
dephosphorylated ASK1, activating as ASK1 signaling path-
way by disassociating ASK1 from its inhibitor 14-3-3. ASK1
is the activator of JNK (Matsuzawa and Ichijo 2008).
Activated ASK1 has been associated with neurotoxicity of
Aβ in CECs (Hsu et al. 2007). Moreover, activated JNK has
been extensively involved in the apoptotic effect of Aβ
(Borsello and Forloni 2007). Inhibition of AIP1 attenuated
the activation of ASK1/JNK/p53 induced by Aβ1-42. More
importantly, AIP1 silencing using siRNA rescued Aβ1-42-
induced apoptosis. These data suggest that up-regulation of
AIP1 might be a novel regulator, involved in the neurotoxicity
of Aβ1-42.
ASK1 is a member of the mitogen-activated protein kinase
kinase kinase (MAPKKK) family which is the upstream sig-
naling molecular of the JNK and p38 MAPK signaling cas-
cades (Saitoh et al. 1998). Studies have reported that ASK1 is
related to various cellular responses including oxidative stress,
cell survival, and apoptosis (Takeda et al. 2000). Importantly,
Aβ neurotoxicity is related to the activation of ASK1 (Song
et al. 2014). Aβ can activate ASK1, leading to the generation
of ROS and ER stress-induced JNK activation (Kadowaki
et al. 2005). Consistent with our current study, a recent study
reported that the activation of the ASK1-MKK3/6-p38MAPK
signaling cascade triggered Aβ-induced cell death in cerebral
endothelial cells (Hsu et al. 2007). Also, Aβ-induced apopto-
sis in SH-SY5Y cells is mediated by activation of the ASK1
cascade (Akterin et al. 2006). In addition, the dimerization of
the cytoplasmic domains of APP induces ASK1- and JNK-
dependent apoptosis in neuronal cells (Hashimoto et al. 2003;
Maruoka et al. 2003). Abnormal tau phosphorylation is an-
other essential pathological event that occurs in AD. Peel and
colleagues demonstrated that the activation of ASK1 is in-
volved in tau phosphorylation (Peel et al. 2004).Multiple lines
of evidence have shown that ASK1 is involved in insulin
signal, which plays an important role in AD pathology such
as cognitive impairment (Aguirre et al. 2000; Craft et al.
1999). Taken together, ASK1 is associatedwith various mech-
anisms in AD pathology. It is suggested to be a potential
therapeutic target for AD.
Based on these observations, we concluded that AIP1
mediates Aβ induced ASK1 activation by facilitating disso-
ciation of 14-3-3, suggesting a novel mechanism for Aβ-
induced apoptosis in CECs.
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